Lim Rui Wen, an analyst from DBS, maintained the Buy rating on Sumitomo Mitsui Financial Group (SMFNF – Research Report). The associated price ...

Sumitomo Pharma recorded core operating income of JPY19.9 billion, a significant year-over-year improvement of JPY116.2 billion. This was attributed to streamlined operations in North America, reduced ...

Sumitomo Mitsui Financial Group, Inc. operates as a holding company, which engages in the management of its subsidiaries that provide financial services. It operates through the following segments ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sumitomo Chemical Co. (Tokyo, Japan) has acquired all shares of Philagro Holding, S.A. (Philagro), its France-based consolidated subsidiary engaged in ...

After hours: January 31 at 5:29:10 PM EST ...